<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00524862</url>
  </required_header>
  <id_info>
    <org_study_id>06368</org_study_id>
    <nct_id>NCT00524862</nct_id>
  </id_info>
  <brief_title>Standard Drug Therapy vs. Implanted Defibrillator for Primary Prevention of Sudden Cardiac Death</brief_title>
  <acronym>SMART-ICD</acronym>
  <official_title>Selective Strategy to Manage Arrhythmia Risk and Therapy With ICD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Michael's Hospital, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institute for Clinical Evaluative Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ontario Ministry of Health and Long Term Care</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>St. Michael's Hospital, Toronto</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recent ACC/AHA/ESC guidelines recommend prophylactic ICD implantation in most patients with
      coronary heart disease and LVEF &lt; 40%. Current Canadian guidelines recommend ICDs for primary
      prophylaxis in CAD patients with LVEF &lt; 30% (Class I recommendation). There are very sparse
      data to recommend ICD implantation in patients with EF between 30 and 40 %. This study will
      randomize patients with CHD and an EF between 30 and 40% to ICD therapy vs. No ICD therapy.
      The primary outcome is mortality and the study is powered as a non-inferiority trial to test
      the hypothesis that mortality in patients with no ICD is not more than 1% greater (absolute
      yearly increase) than patients receiving an ICD.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Poor recruitment
  </why_stopped>
  <start_date>October 2007</start_date>
  <completion_date type="Actual">April 2011</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>minimum 1 year follow-up (maximum 6 year)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>1. Presumed arrhythmic (sudden death) mortality. 2. Major morbidity which includes mortality, hospitalization and major device complications</measure>
    <time_frame>minimum 1 year; maximum 6 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Coronary Heart Disease</condition>
  <condition>Congestive Heart Failure</condition>
  <condition>Ventricular Dysfunction</condition>
  <condition>Low Cardiac Output</condition>
  <condition>Sudden Cardiac Death</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Optimized medical therapy</intervention_name>
    <description>Beta Blockers, ACE inhibitor or ARB, loop diuretics and/or spironolactone as appropriate, statin if indicated, aspirin and/or warfarin if indicated</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Implantable Cardioverter Defibrillator</intervention_name>
    <description>an implanted device, called a defibrillator, which monitors heart rhythm and treats life-threatening rhythms accordingly</description>
    <arm_group_label>2</arm_group_label>
    <other_name>ICD</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  documented chronic coronary heart disease (prior MI and/or angiographically documented
             CAD), &gt; 40 days post the most recent MI;

          -  LVEF &lt; 40% (by MUGA) and NYHA functional class II or III at time of assessment OR LVEF
             ≤ 35 % (by MUGA) and NYHA functional class I, II or III at time of assessment

          -  Judged to have a reasonable expectation of survival with a good functional status for
             more than 1 year, as well as receiving optimum, guideline recommended therapy for
             coronary artery disease and heart failure (or demonstrated intolerance or
             contraindications to such therapy).

          -  Age ≥ 18 years; no upper age limitation.

        Exclusion Criteria:

          -  Prior cardiac arrest, sustained VT or VF, or unexplained syncope.

          -  Attempted VT / VF induction at electrophysiological study.

          -  Need for a cardiac resynchronization therapy (CRT) device.

          -  Enrollment in another interventional trial.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul Dorian, MD</last_name>
    <role>Study Chair</role>
    <affiliation>St. Michael's Hospital, Toronto</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andreas Laupacis, MD</last_name>
    <role>Study Director</role>
    <affiliation>Li Ka Shing Knowledge Institute at St. Michael's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Douglas Lee, MD</last_name>
    <role>Study Director</role>
    <affiliation>Institute for Clinical Evaluatuve Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kevin Thorpe, MSc</last_name>
    <role>Study Director</role>
    <affiliation>Li Ka Shing Knowledge Institute at St. Michael's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marta Gadacz, MSc</last_name>
    <role>Study Director</role>
    <affiliation>St. Michael's Hospital, Toronto</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hamilton Health Sciences - Hamilton General</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8L 2X2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kingston General Hospital</name>
      <address>
        <city>Kingston</city>
        <state>Ontario</state>
        <zip>K7L 2V7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>London Health Sciences - University Campus</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5A5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Trillium Health Centre - Mississauga</name>
      <address>
        <city>Mississauga</city>
        <state>Ontario</state>
        <zip>L5B 1B8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southlake Regional Health Centre</name>
      <address>
        <city>Newmarket</city>
        <state>Ontario</state>
        <zip>L3Y 2P9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Ottawa Heart Institute</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1Y 4W7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rouge Valley Health System - Centenary</name>
      <address>
        <city>Scarborough</city>
        <state>Ontario</state>
        <zip>M1E 5E9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sunnybrook Health Sciences Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4N 3M5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Michael's Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5B 1W8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Health Network - Toronto General Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2C4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 29, 2007</study_first_submitted>
  <study_first_submitted_qc>August 31, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 5, 2007</study_first_posted>
  <last_update_submitted>July 30, 2015</last_update_submitted>
  <last_update_submitted_qc>July 30, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 31, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Implantable Cardioverter Defibrillator</keyword>
  <keyword>Ejection Fraction</keyword>
  <keyword>QRS duration</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Death</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Ventricular Dysfunction</mesh_term>
    <mesh_term>Death, Sudden, Cardiac</mesh_term>
    <mesh_term>Cardiac Output, Low</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

